Invasive therapies, especially the implantable cardioverter-defibrillator (ICD) have become important treatment options for patients with inherited cardiac arrhythmia syndromes who are at risk of sudden cardiac death (SCD). Louise Olde Nordkamp provides evidence for the optimization of the benefit-harm equilibrium of treatment in patients with inherited cardiac arrhythmia syndromes, evaluating current treatment strategies and testing new treatment options which aim to minimise therapy harm.
L.R.A. Olde Nordkamp, Invasive Therapy for Inherited Cardiac Arrhythmias: Towards a better Benefit-Risk Equilibrium.
Prof. A.A.M. Wilde
Dr J.R. de Groot
Dr N. van Dijk
This event is open to the public.